09.03.2011Frost & Sullivan Award Commends AugurixYou are hereNewsFrost & Sullivan Award Commends Augurix
The 2010 Frost & Sullivan European Product Differentiation Excellence Award in Point of Care Testing is presented to Augurix. The company is honored for developing the Simtomax test - the only known point of care test for screening Celiac disease that reaches lab-accurate results.
The Product Differentiation Excellence Award is awarded to the company that has excelled in the following criteria: unique features/functionality, quality/complexity, matched to target markets needs and brand perception of the uniqueness of the product.
BioAlps World Visibitlity Package 201918.03.2019A yearly international programme for our affiliated companies to increase their visibility.
BioAlps World Visibitlity Package 2019A yearly international programme for our affiliated companies to increase their visibility.
HealthCare Konnect (HC2 HealthCare & Pharma Consulting SA)Professional Services & Consulting, Business Development Services
HC2 strives to get new therapies to African countries, as there is a growing need for novel efficacious and safe treatments beyond generics
Professional Services & Consulting, Regulatory & Clinical Services
We offer shared regional offices for healthcare companies who want to commercialise their innovative pharmaceutical products or medical devices in Africa.
We offer our clients "peace of mind" by giving them access to and managing for them two regional offices in the North and Subsaharan markets with a team of experts and a trusted network of local distributors - in more than 15 countries across the region.
We have a proven track record with Swiss and ROW innovative companies.
By collaborating with HC2 you will gain guaranteed access to a unique distribution network in Africa, and benefit from direct contacts with key opinion leaders and therapeutic area experts in target countries, doctors and pharmacists, as well as professional qualified marketing and sales teams with years of experience to assist you.